Regulatory mechanisms and clinical applications of tumor-driven exosomal circRNAs in cancers

被引:3
作者
Meng, Xiangyu [1 ]
Yang, Dong [1 ]
Zhang, Bao [1 ]
Zhao, Yan [1 ]
Zheng, Zhichao [1 ]
Zhang, Tao [1 ,2 ]
机构
[1] China Med Univ, Liaoning Canc Hosp, Canc Hosp, Dept Gastr Surg, Shenyang, Liaoning, Peoples R China
[2] China Med Univ, Liaoning Canc Hosp, Canc Hosp, Dept Gastr Surg, 44 Xiaoheyan Rd, Shenyang 110042, Liaoning, Peoples R China
来源
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2023年 / 20卷 / 06期
关键词
cancer; tumor-driven exosomes; exosomal circRNAs; mechanisms; clinical application; HEPATOCELLULAR-CARCINOMA; MATRIX METALLOPROTEINASES; COLORECTAL-CANCER; PROSTATE-CANCER; PLASMA EXOSOMES; SERUM EXOSOMES; OVARIAN-CANCER; CIRCULAR RNAS; STEM-CELLS; PROMOTES;
D O I
10.7150/ijms.82419
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malignant tumors seriously affect people's survival and prognosis. Exosomes, as vesicle structures widely existing in human tissues and body fluids, are involved in cell-to-cell transmission. Tumor-derived exosomes were secreted from tumors and involved in the development of carcinogenesis. Circular RNA (circRNA), a novel member of endogenous noncoding RNAs, is widespread in human and play a vital role in many physiological or pathological processes. Tumor-driven exosomal circRNAs are often involved in tumorigenesis and development including the proliferation, invasion, migration and chemo-or-radiotherapy sensitivity of tumor cell by multiple regulatory mechanisms. In this review, we will elaborate the roles and functions of tumor-driven exosomal circRNAs in cancers which may be used as potential cancer biomarkers and novel therapeutic targets.
引用
收藏
页码:818 / 835
页数:18
相关论文
共 179 条
  • [1] Non-coding RNA networks in cancer
    Anastasiadou, Eleni
    Jacob, Leni S.
    Slack, Frank J.
    [J]. NATURE REVIEWS CANCER, 2018, 18 (01) : 5 - 18
  • [2] Aplin AE, 1998, PHARMACOL REV, V50, P197
  • [3] Histone Modifications and Cancer
    Audia, James E.
    Campbell, Robert M.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2016, 8 (04):
  • [4] Utilisation of Nanoparticle Technology in Cancer Chemoresistance
    Ayers, Duncan
    Nasti, Alessandro
    [J]. JOURNAL OF DRUG DELIVERY, 2012, 2012
  • [5] Bai L, 2022, ANTI-CANCER DRUG, V33, P409
  • [6] Radiation therapy and cancer control in developing countries: Can we save more lives?
    Baskar, Rajamanickam
    Itahana, Koji
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2017, 14 (01): : 13 - 17
  • [7] Epigenetic regulation in cancer progression
    Baxter, Eva
    Windloch, Karolina
    Gannon, Frank
    Lee, Jason S.
    [J]. CELL AND BIOSCIENCE, 2014, 4
  • [8] The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
    Bruni, Daniela
    Angell, Helen K.
    Galon, Jerome
    [J]. NATURE REVIEWS CANCER, 2020, 20 (11) : 662 - 680
  • [9] Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5
    Chang, Zhiwei
    Fu, Yang
    Jia, Yongxu
    Gao, Ming
    Song, Lijie
    Zhang, Weijie
    Zhao, Ruihua
    Qin, Yanru
    [J]. CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [10] Perivascular Nitric Oxide Activates Notch Signaling and Promotes Stem-like Character in PDGF-Induced Glioma Cells
    Charles, Nikki
    Ozawa, Tatsuya
    Squatrito, Massimo
    Bleau, Anne-Marie
    Brennan, Cameron W.
    Hambardzumyan, Dolores
    Holland, Eric C.
    [J]. CELL STEM CELL, 2010, 6 (02) : 141 - 152